|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 43/23 | (2006.01) |
| C07C 43/23 | (2013.01) | ||
| C07C 41/26 | (2006.01) | ||
| C07D 317/22 | (2013.01) | ||
| C07D 303/04 | (2006.01) | ||
| C07D 407/06 | (2013.01) | ||
| C07D 301/24 | (2006.01) | ||
| C07F 7/1804 | (2013.01) | ||
| C07D 317/22 | (2006.01) | ||
| C07F 7/081 | (2013.01) | ||
| C07D 407/06 | (2006.01) | ||
| C07F 7/083 | (2013.01) | ||
| C07F 7/08 | (2006.01) | ||
| C07F 7/188 | (2013.01) | ||
| C07F 7/18 | (2006.01) | ||
| C07F 7/1892 | (2013.01) | ||
| Y02P 20/55 | (2015.11) |
| (11) | Patento numeris | 3925948 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20796052.7 |
| Europos patento paraiškos padavimo data | 2020-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-12-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2020/082933 |
| Data | 2020-04-02 |
| (87) | Numeris | WO 2020/216034 |
| Data | 2020-10-29 |
| (30) | Numeris | Data | Šalis |
| 201910346140 | 2019-04-26 | CN |
| (72) |
XU, Weiping , CN
|
| (73) |
Beijing Tienyi Lufu Pharmatech Co. Ltd. ,
Room 431, Floor 4, Building 2
No. 18 Long Qing Street
Beijing Economic and
Technological Development Zone, Beijing 100176,
CN
|
| (54) | INTERMEDIATE OF ERIBULIN, SYNTHESIS METHOD THEREFOR AND USE THEREOF |
| INTERMEDIATE OF ERIBULIN, SYNTHESIS METHOD THEREFOR AND USE THEREOF |